miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Breast cancer remains a leading cause of cancer-related mortality worldwide.
• MicroRNAs (miRNAs) are crucial regulators of gene expression, often dysregulated in cancer, influencing tumor progression and metastasis.
• miRNAs can function as either oncogenes or tumor suppressors.

Purpose of the Study:

• To investigate the role of miR-433 in breast cancer.
• To elucidate the mechanism by which miR-433 affects breast cancer cell apoptosis, migration, and proliferation.
• To identify and validate the molecular targets of miR-433 in breast cancer.

Main Methods:

• Bioinformatic analysis to predict miR-433 targets.
• Experimental validation of miR-433 targets using overexpression and knockdown techniques.
• Assessment of breast cancer cell apoptosis, migration, and proliferation.
• Analysis of the MAPK signaling pathway activation.

Main Results:

• miR-433 expression is significantly decreased in breast cancer cells.
• Rap1a was identified as a direct target of miR-433, with inverse correlation in expression levels.
• miR-433 overexpression suppressed breast cancer cell migration and proliferation while enhancing apoptosis.
• Rap1a activation of the MAPK signaling pathway was linked to increased cell migration, proliferation, and inhibited apoptosis.

Conclusions:

• miR-433 functions as a tumor suppressor gene in breast cancer.
• The miR-433/Rap1a axis regulates breast cancer progression and metastasis.
• Targeting miR-433 may offer a potential therapeutic strategy for breast cancer treatment.